Biotech is now the deepest pocket of leadership in the entire Nasdaq. Everyone can see biotech is moving, and the why is ...

Current Portfolio Allocation for Core Biotech1. Selling my stake in Abcellera Biologics (ABCL) for 18% loss2. Adding to my position in Axsome Therapeutics (AXSM), increasing portfolio weighting from 4 ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

Later this month, BIO will hold its annual conference. BIO provides advocacy, business development, and communications services for its members worldwide. BIO came into existence in 1993 through the ...

BIO, the world’s largest trade group for the biotechnology industry, has gone from trying to water down proposed US legislation to sever ties with Chinese health care companies, to supporting it.